Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,834 | 35,841 | 39,878 | 39,040 | 31,150 |
| Marketable Securities | 88,259 | 92,325 | 79,228 | 64,012 | 88,625 |
| Receivables | 325 | 373 | 298 | 346 | 431 |
| TOTAL | $117,635 | $135,338 | $128,856 | $123,068 | $132,935 |
| Non-Current Assets | |||||
| PPE Net | 1,293 | 1,531 | 1,620 | 1,764 | 1,899 |
| Investments And Advances | 38,778 | 33,199 | 62,771 | 83,944 | 90,992 |
| Intangibles | 0 | 0 | 0 | 6,917 | 6,935 |
| Other Non-Current Assets | 3,365 | 3,997 | 4,158 | 2,661 | 2,888 |
| TOTAL | $43,436 | $38,727 | $68,549 | $95,286 | $102,714 |
| Total Assets | $161,071 | $174,065 | $197,405 | $218,354 | $235,649 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,269 | 10,810 | 8,878 | 9,648 | 11,425 |
| Accrued Expenses | 5,762 | 6,565 | 19,446 | 15,160 | 8,744 |
| Other current liabilities | N/A | N/A | 2,628 | N/A | N/A |
| TOTAL | $15,682 | $20,080 | $30,952 | $27,320 | $22,829 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11,567 | 11,971 | 9,274 | 34,334 | 32,703 |
| TOTAL | $11,567 | $11,971 | $9,274 | $34,701 | $33,070 |
| Total Liabilities | $27,249 | $32,051 | $40,226 | $62,021 | $55,899 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,345 | 71,265 | 70,925 | 70,836 | 70,795 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -798,723 | -787,737 | -770,796 | -769,305 | -740,044 |
| Other shareholders' equity | -463 | -364 | -106 | -1,129 | -1,111 |
| TOTAL | $133,822 | $142,014 | $157,179 | $156,333 | $179,750 |
| Total Liabilities And Equity | $161,071 | $174,065 | $197,405 | $218,354 | $235,649 |